Development Level
Tbio | 39 | 11,445 | |
Tchem | 4 | 1,598 | |
Tdark | 3 | 6,588 | |
Tclin | 1 | 613 |
Collection
Kinase: IDG Consortium (Target... | 2 | 125 | |
RFA-RM-18-021 | 2 | 328 |
IMPC Phenotype
preweaning lethality, complete... | 9 | 979 | |
abnormal bone structure | 4 | 187 | |
increased heart weight | 4 | 62 | |
increased startle reflex | 4 | 112 | |
increased circulating alkaline... | 3 | 122 | |
increased circulating total pr... | 3 | 28 | |
decreased mean corpuscular hem... | 2 | 50 | |
embryonic lethality prior to o... | 2 | 239 | |
increased circulating creatini... | 2 | 38 | |
preweaning lethality, incomple... | 2 | 499 | |
abnormal behavior | 1 | 298 | |
abnormal embryo size | 1 | 220 | |
abnormal embryo turning | 1 | 31 | |
abnormal lens morphology | 1 | 81 | |
abnormal lung morphology | 1 | 26 | |
abnormal retina morphology | 1 | 71 | |
abnormal seminal vesicle morph... | 1 | 114 | |
abnormal sleep behavior | 1 | 70 | |
cardiovascular system phenotyp... | 1 | 36 | |
cataract | 1 | 92 | |
decreased caudal vertebrae num... | 1 | 53 | |
decreased circulating chloride... | 1 | 30 | |
decreased circulating choleste... | 1 | 93 | |
decreased circulating sodium l... | 1 | 22 | |
decreased circulating triglyce... | 1 | 79 | |
decreased fasted circulating g... | 1 | 65 | |
decreased hematocrit | 1 | 46 | |
decreased large unstained cell... | 1 | 11 | |
decreased neutrophil cell numb... | 1 | 42 | |
decreased total body fat amoun... | 1 | 207 | |
decreased vertical activity | 1 | 208 | |
embryonic growth retardation | 1 | 106 | |
embryonic lethality prior to t... | 1 | 278 | |
enlarged lymph nodes | 1 | 37 | |
impaired glucose tolerance | 1 | 75 | |
impaired righting response | 1 | 26 | |
increased blood urea nitrogen ... | 1 | 48 | |
increased circulating HDL chol... | 1 | 80 | |
increased circulating fructosa... | 1 | 13 | |
increased circulating potassiu... | 1 | 29 | |
increased circulating serum al... | 1 | 22 | |
increased circulating sodium l... | 1 | 71 | |
increased circulating thyroxin... | 1 | 7 | |
increased erythrocyte cell num... | 1 | 39 | |
increased hematocrit | 1 | 46 | |
increased lymphocyte cell numb... | 1 | 32 | |
microphthalmia | 1 | 26 | |
persistence of hyaloid vascula... | 1 | 33 | |
prolonged QT interval | 1 | 38 | |
prolonged ST segment | 1 | 36 |
Disease
Tissue
Endocrine System | 44 | 18,159 | |
Urinary Tract | 43 | 16,678 | |
Blood and immune system | 42 | 16,909 | |
Digestive Tract | 42 | 17,369 | |
Liver and Pancreas | 42 | 16,750 | |
Male tissues | 42 | 17,142 | |
Skin and soft tissues | 42 | 17,230 | |
Female tissues | 41 | 17,400 | |
Nervous System | 41 | 16,725 | |
Cardiovascular System | 40 | 15,192 | |
Respiratory system | 40 | 16,393 |
Target Family
Non-IDG | 27 | 12,091 | |
Enzyme | 9 | 4,145 | |
Transcription Factor | 7 | 1,400 | |
Kinase | 3 | 634 | |
GPCR | 1 | 408 |
KEGG Pathway
Vasopressin-regulated water re... | 47 | 47 | |
Metabolic pathways | 1,263 | 1,263 | |
Pathways in cancer | 530 | 530 | |
Olfactory transduction | 414 | 414 | |
Human papillomavirus infection | 388 | 388 | |
PI3K-Akt signaling pathway | 349 | 349 | |
HTLV-I infection | 336 | 336 | |
Endocytosis | 310 | 310 | |
MAPK signaling pathway | 295 | 295 | |
Epstein-Barr virus infection | 280 | 280 | |
Neuroactive ligand-receptor in... | 276 | 276 | |
Cytokine-cytokine receptor int... | 267 | 267 | |
Herpes simplex infection | 262 | 262 | |
Kaposi's sarcoma-associated he... | 252 | 252 | |
Viral carcinogenesis | 251 | 251 | |
Thermogenesis | 232 | 232 | |
Ras signaling pathway | 230 | 230 | |
Phagosome | 229 | 229 | |
Cellular senescence | 228 | 228 | |
Cell adhesion molecules (CAMs) | 225 | 225 | |
Rap1 signaling pathway | 209 | 209 | |
Regulation of actin cytoskelet... | 207 | 207 | |
cAMP signaling pathway | 201 | 201 | |
Focal adhesion | 198 | 198 | |
Proteoglycans in cancer | 198 | 198 | |
Natural killer cell mediated c... | 197 | 197 | |
Huntington's disease | 194 | 194 | |
Tuberculosis | 189 | 189 | |
Calcium signaling pathway | 183 | 183 | |
Chemokine signaling pathway | 183 | 183 | |
Influenza A | 182 | 182 | |
Axon guidance | 174 | 174 | |
Purine metabolism | 172 | 172 | |
Alzheimer's disease | 171 | 171 | |
Transcriptional misregulation ... | 171 | 171 | |
Tight junction | 169 | 169 | |
Hepatocellular carcinoma | 168 | 168 | |
NOD-like receptor signaling pa... | 166 | 166 | |
Protein processing in endoplas... | 164 | 164 | |
RNA transport | 163 | 163 | |
cGMP-PKG signaling pathway | 162 | 162 | |
Jak-STAT signaling pathway | 161 | 161 | |
Cushing's syndrome | 158 | 158 | |
Antigen processing and present... | 156 | 156 | |
Hippo signaling pathway | 154 | 154 | |
Necroptosis | 154 | 154 | |
Oxytocin signaling pathway | 154 | 154 | |
MicroRNAs in cancer | 150 | 150 | |
mTOR signaling pathway | 150 | 150 | |
Non-alcoholic fatty liver dise... | 149 | 149 | |
Gastric cancer | 148 | 148 | |
Retrograde endocannabinoid sig... | 148 | 148 | |
Adrenergic signaling in cardio... | 147 | 147 | |
Alcoholism | 147 | 147 | |
Breast cancer | 147 | 147 | |
Phospholipase D signaling path... | 147 | 147 | |
Wnt signaling pathway | 145 | 145 | |
Hepatitis B | 143 | 143 | |
Parkinson's disease | 142 | 142 | |
Estrogen signaling pathway | 139 | 139 | |
Apoptosis | 138 | 138 | |
Fluid shear stress and atheros... | 138 | 138 | |
Signaling pathways regulating ... | 138 | 138 | |
Insulin signaling pathway | 137 | 137 | |
Ubiquitin mediated proteolysis | 137 | 137 | |
Viral myocarditis | 137 | 137 | |
Apelin signaling pathway | 136 | 136 | |
Dopaminergic synapse | 135 | 135 | |
Ribosome | 134 | 134 | |
Measles | 133 | 133 | |
Oxidative phosphorylation | 133 | 133 | |
Relaxin signaling pathway | 133 | 133 | |
Spliceosome | 132 | 132 | |
Autoimmune thyroid disease | 130 | 130 | |
FoxO signaling pathway | 130 | 130 | |
Hepatitis C | 130 | 130 | |
Autophagy - animal | 128 | 128 | |
Osteoclast differentiation | 127 | 127 | |
Cell cycle | 125 | 125 | |
Platelet activation | 125 | 125 | |
Toxoplasmosis | 125 | 125 | |
Lysosome | 123 | 123 | |
Vascular smooth muscle contrac... | 123 | 123 | |
Type I diabetes mellitus | 122 | 122 | |
Oocyte meiosis | 121 | 121 | |
AMPK signaling pathway | 120 | 120 | |
Graft-versus-host disease | 120 | 120 | |
Neurotrophin signaling pathway | 119 | 119 | |
Th17 cell differentiation | 119 | 119 | |
Sphingolipid signaling pathway | 118 | 118 | |
Allograft rejection | 116 | 116 | |
Carbon metabolism | 116 | 116 | |
Glutamatergic synapse | 116 | 116 | |
Thyroid hormone signaling path... | 116 | 116 | |
Serotonergic synapse | 114 | 114 | |
Leukocyte transendothelial mig... | 112 | 112 | |
Cholinergic synapse | 111 | 111 | |
Hematopoietic cell lineage | 108 | 108 | |
Systemic lupus erythematosus | 108 | 108 | |
TNF signaling pathway | 108 | 108 | |
Insulin resistance | 107 | 107 |
This is where graphics are reside..